Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Samsung Biologics Chooses STARLIMS

Published: Saturday, June 02, 2012
Last Updated: Saturday, June 02, 2012
Bookmark and Share
STARLIMS will provide Samsung its LIMS software to help enhance functional support for quality assurance laboratory testing and for storing and delivering analytical test results.

Samsung is known for electronics not biotechnology, but that could change in future years as Samsung Biologics has opened a new state of the art biologics development and production facility in Incheon, Korea.  To assure ongoing compliance with biologics manufacturing quality standards, Samsung BioLogics chose STARLIMS to be its LIMS provider. 

 “STARLIMS will provide Samsung its LIMS software to help enhance functional support for quality assurance laboratory testing and for storing and delivering analytical test results,” said Thomas Li, account manager, STARLIMS Asia Pacific.  “STARLIMS passed a thorough audit and evaluation by Samsung Biologics, which demonstrates our capability to support the business needs of a world class customer operating a large contract product development and manufacturing facility.”

The new Incheon facility will develop and manufacture a wide range of biologics products through genetic engineering technologies, cell culturing and purification.  By 2013, Samsung Biologics will offer a broad range of mammalian cell based, cGMP manufacturing services for cell line development, process and analytical development, clinical and commercial manufacturing, as well as aseptic fill and finish operations.


“Our biologics facility is capable of producing high quality bulk drug products.  We are pleased that our quality control department is relying on STARLIMS leading edge laboratory informatics solutions to help guarantee that all process and final production are high quality, meet global regulatory standards, and maximize customer satisfaction,” said Ming fang Hong, quality control team leader, Samsung Biologics. 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
Food and Drug Administration will begin implementing Abbott’s STARLIMS LIMS as part of the agency’s initiative to enhance FDA testing laboratories.
Monday, July 09, 2012
STARLIMS Acquires Distributor in Australia
Abbott has acquired STARLIMS’s Asia Pacific distribution partner.
Saturday, June 02, 2012
STARLIMS Expanding Global Market Presence in Forensics
STARLIMS is expanding its worldwide presence in the forensics market with products and applications designed for crime labs, evidence collection teams and police property rooms.
Saturday, June 02, 2012
STARLIMS to Provide LIMS to Australian Red Cross Blood Services
STARLIMS' LIMS software has been adopted by the Australian Red Cross Blood Services (ARCBS) to manage information and data in its blood products manufacturing and transplantation laboratories.
Saturday, June 02, 2012
Abbott’s STARLIMS Business Acquires Distribution Partners to Build International Presence
Acquisitions part of a series of strategic moves to build Abbott's LIMS business in Europe and emerging markets in Latin America and Africa
Saturday, May 12, 2012
STARLIMS Expands Global Customer Service and Support
Resources from Abbott help build new, global customer care organization
Wednesday, April 25, 2012
STARLIMS Acquires International Distribution Partners
STARLIMS Technologies, an Abbott company, has announced the acquisition of several longtime distribution partners
Sunday, March 11, 2012
StarLIMS wins FDA software deal
The company will supply its lab management solutions for FDA testing laboratories.
Wednesday, February 01, 2012
Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
STARLIMS and Abbott have announced that the FDA will begin implementing STARLIMS LIMS solution as part of the agency’s initiative to enhance FDA’s testing laboratories.
Tuesday, January 24, 2012
Dr Lal PathLabs Selects STARLIMS Software for LIMS
STARLIMS will be implemented for use in its entire network consisting of the National Reference Lab (NRL) in New Delhi
Tuesday, November 29, 2011
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos